Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

November 07, 2014

FDA MedWatch - Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall - Software Issue May Stop Ventilator


FDA MedWatch Nellcor Puritan Bennett 980 Ventilator System Class I Recall



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Testifies Before FDA on Safe Use of Propofol

ASA Immediate Past President Eugene P. Sinclair, M.D. testified before the FDA Advisory Committee on Anesthetic and Life Support Drugs on November 10, 2005. At issue was the petition filed by the American College of Gastroenterology to remove from the propofol (Diprivan®) labeling the following language:

“For general anesthesia or monitored anesthesia care (MAC) sedation, DIPRIVAN Injectable Emulsion should be administered only by persons trained in the administration of general anesthesia and not involved in the conduct of the surgical/diagnostic procedure.”

Dr. Sinclair was followed at the podium by anesthesiologists Carol Rose, M.D., of the University of Pittsburgh Medical Center, and until recently a member of the Advisory Committee, and Marc Koch, M.D., M.B.A., President and Chief Executive Officer of Somnia, Inc., a New York based Anesthesia Management Company, which specializes in providing comprehensive anesthesia, pain management and accreditation consulting services to office-based surgical facilities and ambulatory surgery centers throughout the United States. These three anesthesiologists were the only witnesses and they each testified in favor of keeping the warning on the propofol labeling.

Download a copy of Dr. Sinclair’s testimony and ASA’s letter commenting on the ACG petition filed with the FDA on October 19.